Sartorius and France-based MAbSilico have entered a non-exclusive collaboration combining AI-powered predictive algorithms from MAbSilico with cell line development (CLD) capabili ...
Now, the technology is making headlines again in cancer treatment. For the first time, a personalised mRNA cancer vaccine has ...
For decades, the complexity of the brain, limited understanding of disease biology and the formidable blood-brain barrier ...
By adding Parafilm M to its portfolio, Avantor India enables customers to source the product alongside chemicals, reagents, ...
On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, an ...
For instance, in March 2026, China’s National Medical Products Administration (NMPA) announced approval of the country's ...
The bottleneck is the specialist appointment More than 240 million people aged 65 and over live in the Western Pacific, a ...
AABB has published a special TRANSFUSION journal supplement examining the growing biotherapies landscape, including cell and ...
The gut-brain axis is moving from an emerging research concept towards a potential platform for precision mental health.
With support from the government of Ontario, Piramal Pharma is investing $5,314,000 to upgrade site infrastructure at their ...
International healthcare leaders should view Taiwan as a top-tier innovator of complete, end-to-end clinical systems” ...
Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPYK04, a ...